Dian Diagnostics Group. 

¥12.75
0
-¥0.28-2.15% 今天

統計

當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
17.53B
市盈率
7.36
股息收益率
0.47%
股息
0.06

即將到來

股息

0.47%股息收益率
10年增長
-5.98%
5年增長率
19.14%
3年增長率
-22.72%
1年增長率
-70%

收益

24Oct預期
Q1 2024
Q2 2024
下一個
0.04
0.15
0.26
0.38
預期每股收益
0.16185279487999998
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 300244.SZ 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.
Show more...
首席執行官
Mr. Haibin Chen B.S. (EMBA)
員工
11123
國家
CN
ISIN
CNE1000015N1

上市公司